Beyond amyloid: A roadmap for integrated, multi-target Alzheimer’s therapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 6-Jun-2026 01:15 ET (6-Jun-2026 05:15 GMT/UTC)
Despite recent FDA approvals of amyloid-targeting antibodies, reversing Alzheimer's disease (AD) remains an ultimate challenge. A new review highlights the shift from single-target treatments to holistic strategies, integrating Tau pathology, genetics, aging, and systemic health factors to pave the way for next-generation interventions.
In a clinical study of children and adults with aniridia, the researchers found that loss of sensitivity is not static but rather progresses with age. This rare disease causes a total or partial absence of the iris. Those affected often experience focusing problems, photophobia, and other complications. The study also reveals alterations in the tear response. Understanding these processes at a basic level is essential for designing more precise therapeutic strategies in the future to help slow deterioration and improve patients’ quality of life.
The most comprehensive study to date into the health effects of collagen supplements found benefits for skin health and significant relief from osteoarthritis symptoms – but no meaningful improvements in sports performance.
Aligned with priorities in Singapore’s Economic Strategy Review to strengthen AI literacy and workforce readiness — and reflecting the recent Budget emphasis on building AI capabilities across sectors — the programme prepares nurses to lead in an increasingly digital and AI-enabled healthcare landscape.